Cargando…
Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous group of tumours with a typical 5 year survival rate of <40 %. DNA methylation in tumour-suppressor genes often occurs at an early stage of tumorigenesis, hence DNA methylation can be used as an early tumour biomarker. S...
Autores principales: | Lim, Yenkai, Wan, Yunxia, Vagenas, Dimitrios, Ovchinnikov, Dmitry A., Perry, Chris F. L., Davis, Melissa J., Punyadeera, Chamindie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034533/ https://www.ncbi.nlm.nih.gov/pubmed/27663357 http://dx.doi.org/10.1186/s12885-016-2785-0 |
Ejemplares similares
-
Salivary miRNA panel to detect HPV-positive and HPV-negative head and neck cancer patients
por: Wan, Yunxia, et al.
Publicado: (2017) -
A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a) expression in head and neck squamous cell carcinoma patients
por: Chai, Ryan C., et al.
Publicado: (2016) -
Current trends in the etiology and diagnosis of HPV-related head and neck cancers
por: Chai, Ryan C, et al.
Publicado: (2015) -
DNA Methylation at the Novel CpG Sites in the Promoter of MED15/PCQAP Gene as a Biomarker for Head and Neck Cancers
por: Ovchinnikov, Dmitry A, et al.
Publicado: (2014) -
Salivary Protein Panel to Diagnose Systolic Heart Failure
por: Zhang, Xi, et al.
Publicado: (2019)